MRG-001

Pharmaceutical preparations for the treatment of spinal cord injury; Pharmaceutical preparations for the treatment of SARS-CoV-2; Pharmaceutical preparations for the treatment of Covid-19; Pharmaceutical preparations for the treatment of Diabetic kidney disease; Pharmaceutical preparations for the treatment of severe burns; Pharmaceutical preparations for the treatment of Keloid; Pharmaceutical preparations for the treatment of Hypertrophic scar; Pharmaceutical preparations for the treatment of Inflammatory bowel disease; Pharmaceutical preparations for the treatment of Acute liver failure; Pharmaceutical preparations for the treatment of Alcoholic hepatitis; Pharmaceutical preparations for the treatment of nonalcoholic steatohepatitis; Pharmaceutical preparations for the treatment of cardiac infarction; Pharmaceutical preparations for the treatment of corneal injury; Pharmaceutical preparations for the treatment of atherosclerosis; Pharmaceutical preparations for wound healing; Pharmaceutical preparations for organ transplantation